Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2025-12-25 @ 2:12 PM
NCT ID: NCT03295266
Description: All treated participants are included.
Frequency Threshold: 0
Time Frame: Up to 14 days
Study: NCT03295266
Study Brief: Single-Dose Pharmacokinetics of MK-3866 in Participants With Hepatic Impairment (MK-3866-006)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Moderate Hepatic Impairment (Panel A) Participants with moderate HI (eGFR of ≤60mL/min/1.73m\^2) received a single IV dose of MK-3866 (150 mg infused over 30 minutes) on Day 1. 0 None 0 5 2 5 View
Severe Hepatic Impairment (Panel B) Participants with severe HI (eGFR of ≤50 mL/min/1.73m\^2) received a single IV dose of MK-3866 (150 mg infused over 30 minutes) on Day 1. 0 None 0 4 1 4 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 20.1 View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 20.1 View
Skin abrasion SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 20.1 View
Dysgeusia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 20.1 View